Zinczuk A, Rorat M, Simon K, Jurek T
Viruses. 2023; 15(7).
PMID: 37515118
PMC: 10383259.
DOI: 10.3390/v15071430.
Yassin A, Shabsigh R, Al-Zoubi R, Aboumarzouk O, Alwani M, Nettleship J
Rev Med Virol. 2022; 33(1):e2395.
PMID: 36056748
PMC: 9537909.
DOI: 10.1002/rmv.2395.
Sansone N, Pereira L, Boschiero M, Valencise F, Fraga A, Marson F
Int J Environ Res Public Health. 2022; 19(15).
PMID: 35897265
PMC: 9331852.
DOI: 10.3390/ijerph19158895.
Jacobsen H, Klein S
Front Immunol. 2021; 12:720952.
PMID: 34531867
PMC: 8438138.
DOI: 10.3389/fimmu.2021.720952.
Berber E, Sumbria D, Canakoglu N
J Infect Public Health. 2021; 14(8):1051-1064.
PMID: 34174535
PMC: 8214867.
DOI: 10.1016/j.jiph.2021.06.007.
Middle East Respiratory Syndrome (MERS) Virus-Pathophysiological Axis and the Current Treatment Strategies.
Alnuqaydan A, Almutary A, Sukamaran A, Yang B, Lee X, Lim W
AAPS PharmSciTech. 2021; 22(5):173.
PMID: 34105037
PMC: 8186825.
DOI: 10.1208/s12249-021-02062-2.
Sex-based differences in severity and mortality in COVID-19.
Alwani M, Yassin A, Al-Zoubi R, Aboumarzouk O, Nettleship J, Kelly D
Rev Med Virol. 2021; 31(6):e2223.
PMID: 33646622
PMC: 8014761.
DOI: 10.1002/rmv.2223.
SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions.
Abdelghany T, Ganash M, Bakri M, Qanash H, Al-Rajhi A, Elhussieny N
Biomed J. 2021; 44(1):86-93.
PMID: 33602634
PMC: 7603957.
DOI: 10.1016/j.bj.2020.10.008.
Geriatric Population During the COVID-19 Pandemic: Problems, Considerations, Exigencies, and Beyond.
Dhama K, Patel S, Kumar R, Rana J, Yatoo M, Kumar A
Front Public Health. 2020; 8:574198.
PMID: 33072713
PMC: 7536316.
DOI: 10.3389/fpubh.2020.574198.
Sex differences underlying preexisting cardiovascular disease and cardiovascular injury in COVID-19.
Medzikovic L, Cunningham C, Li M, Amjedi M, Hong J, Ruffenach G
J Mol Cell Cardiol. 2020; 148:25-33.
PMID: 32835666
PMC: 7442559.
DOI: 10.1016/j.yjmcc.2020.08.007.
Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer.
Cattrini C, Bersanelli M, Latocca M, Conte B, Vallome G, Boccardo F
Cancers (Basel). 2020; 12(8).
PMID: 32824674
PMC: 7464909.
DOI: 10.3390/cancers12082325.
A gendered magnifying glass on COVID-19.
Salvati L, Biagioni B, Vivarelli E, Parronchi P
Clin Mol Allergy. 2020; 18:14.
PMID: 32774170
PMC: 7402393.
DOI: 10.1186/s12948-020-00129-2.
Gender Difference Is Associated With Severity of Coronavirus Disease 2019 Infection: An Insight From a Meta-Analysis.
Ueyama H, Kuno T, Takagi H, Krishnamoorthy P, Vengrenyuk Y, Sharma S
Crit Care Explor. 2020; 2(6):e0148.
PMID: 32696011
PMC: 7314340.
DOI: 10.1097/CCE.0000000000000148.
Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity.
Sturley S, Rajakumar T, Hammond N, Higaki K, Marka Z, Marka S
J Lipid Res. 2020; 61(7):972-982.
PMID: 32457038
PMC: 7328045.
DOI: 10.1194/jlr.R120000851.
Severity of coronavirus respiratory tract infections in adults admitted to acute care in Toronto, Ontario.
Kozak R, Prost K, Yip L, Williams V, Leis J, Mubareka S
J Clin Virol. 2020; 126:104338.
PMID: 32278299
PMC: 7142695.
DOI: 10.1016/j.jcv.2020.104338.
Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain.
Zhou Y, Yang Y, Huang J, Jiang S, Du L
Viruses. 2019; 11(1).
PMID: 30646569
PMC: 6357101.
DOI: 10.3390/v11010060.
TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections.
Shen L, Mao H, Wu Y, Tanaka Y, Zhang W
Biochimie. 2017; 142:1-10.
PMID: 28778717
PMC: 7116903.
DOI: 10.1016/j.biochi.2017.07.016.
Comparative epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia and South Korea.
Chen X, Chughtai A, Dyda A, MacIntyre C
Emerg Microbes Infect. 2017; 6(6):e51.
PMID: 28588290
PMC: 5520315.
DOI: 10.1038/emi.2017.40.
Modeling the Transmission of Middle East Respirator Syndrome Corona Virus in the Republic of Korea.
Xia Z, Zhang J, Xue Y, Sun G, Jin Z
PLoS One. 2015; 10(12):e0144778.
PMID: 26690750
PMC: 4686901.
DOI: 10.1371/journal.pone.0144778.